News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Curidium Medica plc-Strategic Review & Board Changes



7/23/2008 8:27:52 AM

LONDON--(Marketwire - July 23, 2008) - Curidium Medica plc, (LSE: CUR), the personalised medicine company focused on bringing the right drug to the right patient, today announced that Gosse B. Bruinsma M.D. is moving from chairman to the position of Non-Executive Director. Dr. Barry Porter, co-founder and currently Non-Executive Director, becomes Chairman, with immediate effect. Dr. Bruinsma has cited his other business obligations and Curidium's need for dedicated leadership at this important time as reasons for the strategic change.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES